356 related articles for article (PubMed ID: 22780207)
1. Diagnosis, progression patterns and prognostication in mastocytosis.
Sperr WR; Valent P
Expert Rev Hematol; 2012 Jun; 5(3):261-74. PubMed ID: 22780207
[TBL] [Abstract][Full Text] [Related]
2. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
3. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
4. Mastocytosis.
Metcalfe DD
Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
[TBL] [Abstract][Full Text] [Related]
5. Current state of biology and diagnosis of clonal mast cell diseases in adults.
Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; García-Montero A; Mollejo M; Orfao A; Escribano L
Int J Lab Hematol; 2012 Oct; 34(5):445-60. PubMed ID: 22551157
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
Valent P; Sperr WR; Schwartz LB; Horny HP
J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature.
Kocabas CN; Yavuz AS; Lipsky PE; Metcalfe DD; Akin C
J Allergy Clin Immunol; 2005 Jun; 115(6):1155-61. PubMed ID: 15940128
[TBL] [Abstract][Full Text] [Related]
8. On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.
Valent P; Ghannadan M; Akin C; Krauth MT; Selzer E; Mayerhofer M; Sperr WR; Arock M; Samorapoompichit P; Horny HP; Metcalfe DD
Eur J Clin Invest; 2004 Aug; 34 Suppl 2():41-52. PubMed ID: 15291805
[TBL] [Abstract][Full Text] [Related]
9. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.
Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
Eur J Haematol; 2012 Jul; 89(1):42-6. PubMed ID: 22469616
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.
Arock M; Valent P
Expert Rev Hematol; 2010 Aug; 3(4):497-516. PubMed ID: 21083038
[TBL] [Abstract][Full Text] [Related]
11. Mastocytosis - an update.
Amon U; Hartmann K; Horny HP; Nowak A
J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
Sotlar K
Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612
[TBL] [Abstract][Full Text] [Related]
13. Molecular defects in mastocytosis: KIT and beyond KIT.
Bibi S; Langenfeld F; Jeanningros S; Brenet F; Soucie E; Hermine O; Damaj G; Dubreuil P; Arock M
Immunol Allergy Clin North Am; 2014 May; 34(2):239-62. PubMed ID: 24745672
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, prognosis, and risk factors in mastocytosis.
Brockow K
Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674
[TBL] [Abstract][Full Text] [Related]
15. New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy.
Valent P; Akin C; Sperr WR; Horny HP; Arock M; Metcalfe DD; Galli SJ
Annu Rev Pathol; 2023 Jan; 18():361-386. PubMed ID: 36270293
[TBL] [Abstract][Full Text] [Related]
16. Biology, classification and treatment of human mastocytosis.
Valent P
Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.
Sánchez-Muñoz L; Teodosio C; Morgado JM; Perbellini O; Mayado A; Alvarez-Twose I; Matito A; Jara-Acevedo M; García-Montero AC; Orfao A; Escribano L
Immunol Allergy Clin North Am; 2014 May; 34(2):297-313. PubMed ID: 24745675
[TBL] [Abstract][Full Text] [Related]
18. Pathology of extramedullary mastocytosis.
Doyle LA; Hornick JL
Immunol Allergy Clin North Am; 2014 May; 34(2):323-39. PubMed ID: 24745677
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
[TBL] [Abstract][Full Text] [Related]
20. Mastocytosis: pathology, genetics, and current options for therapy.
Valent P; Akin C; Sperr WR; Mayerhofer M; Födinger M; Fritsche-Polanz R; Sotlar K; Escribano L; Arock M; Horny HP; Metcalfe DD
Leuk Lymphoma; 2005 Jan; 46(1):35-48. PubMed ID: 15621779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
